|
|
||||||||
The Squibb Institute for Medical Research, New Brunswick, New Jersey
Correspondence: For reprints contact: Rama K. Narra, PhD, The Squibb Institute for Medical Research, P.O. Box 191. New Brunswick, NJ 08903-0191.
ABSTRACT
Technetium-99m-DMG-2MP (Chloro[bis{2,3-butanedionedioxime (1)0} {2,3-butanedionedioximato (2)N,N',N'',N''',N'''',N'''''} (2-methylpropyl borato (2)) technetium]), also known as SQ 32097 is a member of a family of neutral lipophilic compounds generally known as boronic acid adducts of technetium dioxime complexes (BATOs). After i.v. administration, the concentration of [99mTc]DMG-2MP in various regions of the brain appears to be proportional to blood flow. In rats, 1.1% ID was in the brain at 5 min postinjection when the blood contained <3% ID. Over 24 hr excretion was 59% in the feces and 23% in the urine. The activity in monkey brain at 5 min was 2.8% ID and it cleared with a t1/2 of 86 min. Autoradiographs of monkey brain sections showed excellent regional detail with a gray/white ratio of 3.6 at 10 min. The distribution of [99mTc]DMG-2MP in the monkey brain corresponds to the known cytoarchitectural pattern of cerebral glucose metabolism. The properties of [99mTc]DMG-2MP make it a potentially useful agent for cerebral perfusion imaging in man.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |